Identification, management, and transition of care for patients with opioid use disorder in the emergency department

HC Duber, IA Barata, E Cioè-Peña, SY Liang… - Annals of emergency …, 2018 - Elsevier
Because of a soaring number of opioid-related deaths during the past decade, opioid use
disorder has become a prominent issue in both the scientific literature and lay press …

Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems

ZM Weinstein, SE Wakeman, S Nolan - Medical Clinics, 2018 - medical.theclinics.com
Previous research has demonstrated not only the feasibility of providing addiction treatment
to individuals in an acute care setting but also its efficacy. A recent metaanalysis …

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

BR Haight, SM Learned, CM Laffont, PJ Fudala, Y Zhao… - The Lancet, 2019 - thelancet.com
Background RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a
subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR …

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial

RD Weiss, JS Potter, DA Fiellin, M Byrne… - Archives of general …, 2011 - jamanetwork.com
Context No randomized trials have examined treatments for prescription opioid
dependence, despite its increasing prevalence. Objective To evaluate the efficacy of brief …

Gender differences in a clinical trial for prescription opioid dependence

RK McHugh, EE DeVito, D Dodd, KM Carroll… - Journal of substance …, 2013 - Elsevier
Although gender differences in substance use disorders have been identified, few studies
have examined gender differences in prescription drug dependence. The aim of this study …

Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone

D Antoine, AS Huhn, EC Strain, G Turner… - … American journal on …, 2021 - Wiley Online Library
Background and Objectives Individuals exposed to fentanyl are at risk of precipitated
withdrawal using typical buprenorphine/naloxone induction procedures. Methods This case …

Attentional bias for nondrug reward is magnified in addiction.

BA Anderson, ML Faulkner, JJ Rilee… - Experimental and …, 2013 - psycnet.apa.org
Attentional biases for drug-related stimuli play a prominent role in addiction, predicting
treatment outcomes. Attentional biases also develop for stimuli that have been paired with …

[HTML][HTML] The prescription opioid addiction treatment study: what have we learned

RD Weiss, V Rao - Drug and alcohol dependence, 2017 - Elsevier
Abstract Background The multi-site Prescription Opioid Addiction Treatment Study (POATS),
conducted by the National Drug Abuse Treatment Clinical Trials Network, was the largest …

[HTML][HTML] Opioid withdrawal

M Shah, MR Huecker - 2018 - europepmc.org
Objectives:< p> Describe the epidemiology of opioid withdrawal syndrome.</p>< p>
Summarize signs and symptoms of opioid withdrawal syndrome.</p>< p> Explain the …

Medical and psychological risks and consequences of long-term opioid therapy in women

BD Darnall, BR Stacey, R Chou - Pain Medicine, 2012 - academic.oup.com
Background. Long-term opioid use has increased substantially over the past decade for US
women. Women are more likely than men to have a chronic pain condition, to be treated with …